天澤信息(300209.SZ):劉智輝擬對其質押的部分公司股票進行違約處置
格隆匯12月25日丨天澤信息(300209.SZ)公佈,公司於近日收到公司持股5%以上的股東(“大股東”)劉智輝,(直接持公司股份2770.5815萬股,佔公司總股本比例6.50%)出具的《減持告知函》,劉智輝計劃自公告披露之日起15個交易日後的6個月內(2020年1月20日-2020年7月19日)通過集中競價交易、大宗交易等證券法律法規所允許的方式對其質押的部分公司股票進行違約處置,擬處置所持公司股份合計不超過839.3454萬股,佔公司總股本比例不超過1.97%,佔公司總股本剔除公司回購專用賬户中的股份數量不超過2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.